BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vervliet T, Gerasimenko JV, Ferdek PE, Jakubowska MA, Petersen OH, Gerasimenko OV, Bultynck G. BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis. Cell Death Discov 2018;4:58. [PMID: 29760956 DOI: 10.1038/s41420-018-0054-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Ivanova H, Vervliet T, Monaco G, Terry LE, Rosa N, Baker MR, Parys JB, Serysheva II, Yule DI, Bultynck G. Bcl-2-Protein Family as Modulators of IP3 Receptors and Other Organellar Ca2+ Channels. Cold Spring Harb Perspect Biol 2020;12:a035089. [PMID: 31501195 DOI: 10.1101/cshperspect.a035089] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
2 Feng S, Wei Q, Hu Q, Huang X, Zhou X, Luo G, Deng M, Lü M. Research Progress on the Relationship Between Acute Pancreatitis and Calcium Overload in Acinar Cells. Dig Dis Sci 2019;64:25-38. [PMID: 30284136 DOI: 10.1007/s10620-018-5297-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Kerkhofs M, Bultynck G, Vervliet T, Monaco G. Therapeutic implications of novel peptides targeting ER-mitochondria Ca2+-flux systems. Drug Discov Today 2019;24:1092-103. [PMID: 30910738 DOI: 10.1016/j.drudis.2019.03.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
4 Spitz AZ, Gavathiotis E. Physiological and pharmacological modulation of BAX. Trends Pharmacol Sci 2021:S0165-6147(21)00216-9. [PMID: 34848097 DOI: 10.1016/j.tips.2021.11.001] [Reference Citation Analysis]